These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28760440)

  • 1. The effect of electroacupuncture on proteomic changes in the motor cortex of 6-OHDA Parkinsonian rats.
    Li M; Li L; Wang K; Su W; Jia J; Wang X
    Brain Res; 2017 Oct; 1673():52-63. PubMed ID: 28760440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model.
    Wang Y; Wang Y; Liu J; Wang X
    Neurosci Bull; 2018 Jun; 34(3):476-484. PubMed ID: 29508251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Group II Metabotropic Glutamate Receptors in the Striatum in Electroacupuncture Treatment of Parkinsonian Rats.
    Jia YJ; Deng JH; Zhang WZ; Sun ZL; Yang J; Yu Y; Gong XL; Jia J; Wang XM
    CNS Neurosci Ther; 2017 Jan; 23(1):23-32. PubMed ID: 27412260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Electroacupuncture on Metabolic Changes in Motor Cortex and Striatum of 6-Hydroxydopamine-Induced Parkinsonian Rats.
    Li M; Wang K; Su WT; Jia J; Wang XM
    Chin J Integr Med; 2020 Sep; 26(9):701-708. PubMed ID: 28986816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-frequency electro-acupuncture stimulation modulates intracerebral γ-aminobutyric acid content in rat model of Parkinson's disease].
    Du J; Sun ZL; Jia J; Wang X; Wang XM
    Sheng Li Xue Bao; 2011 Aug; 63(4):305-10. PubMed ID: 21861048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
    Bagga V; Dunnett SB; Fricker RA
    Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
    Lin L; Yan M; Wu B; Lin R; Zheng Z
    Brain Res Bull; 2018 Sep; 142():338-343. PubMed ID: 30172737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats.
    Jia J; Sun Z; Li B; Pan Y; Wang H; Wang X; Yu F; Liu L; Zhang L; Wang X
    Behav Brain Res; 2009 Dec; 205(1):214-8. PubMed ID: 19549545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
    Westphal R; Sumiyoshi A; Simmons C; Mesquita M; Wood TC; Williams SC; Vernon AC; Cash D
    Neuroscience; 2016 Oct; 334():166-179. PubMed ID: 27506141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.
    Delattre AM; Kiss A; Szawka RE; Anselmo-Franci JA; Bagatini PB; Xavier LL; Rigon P; Achaval M; Iagher F; de David C; Marroni NA; Ferraz AC
    Neurosci Res; 2010 Mar; 66(3):256-64. PubMed ID: 19941911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.
    Fine JM; Forsberg AC; Renner DB; Faltesek KA; Mohan KG; Wong JC; Arneson LC; Crow JM; Frey WH; Hanson LR
    Brain Res; 2014 Jul; 1574():96-104. PubMed ID: 24928620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
    Howells FM; Russell VA; Mabandla MV; Kellaway LA
    Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
    Zhang W; Zhang L; Liu L; Wang X
    Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.
    Truong L; Allbutt H; Kassiou M; Henderson JM
    Behav Brain Res; 2006 Apr; 169(1):1-9. PubMed ID: 16413939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.
    Lindenbach D; Conti MM; Ostock CY; Dupre KB; Bishop C
    Neuroscience; 2015 Dec; 310():12-26. PubMed ID: 26363150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
    Chen L; Zhang QJ; Liu J; Wang S; Ali U; Gui ZH; Wang Y
    Brain Res; 2009 Aug; 1286():192-200. PubMed ID: 19545547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease.
    Henderson J; Doherty K; Allbutt H; Billing R
    Behav Brain Res; 2006 Apr; 169(1):29-38. PubMed ID: 16406102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.